Filing Date | 
					T Date | 
					Ticker | 
										Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/18 16:05  | 4/2/18  | NVTA | Health | Health | Medical Laboratories | Scott Randal W | CA | DO | Exec CB | P | 200 | 4.50 | 0 | 44 | 1 | 3,551 | I | ||||||||||||||
3/29/18 15:59  | 3/28/18  | NVTA | Health | Health | Medical Laboratories | Baker Bros. Advisors LP | NY | T | P | 5,000 | 4.50 | 0 | 1,111 | 17 | 7,554 | I | |||||||||||||||
11/22/16 18:07  | 11/22/16  | NVTA | Health | Health | Medical Laboratories | Scott Randal W | CA | DOT | CB,CEO | P | 400 | 6.00 | 4 | 67 | 2 | 3,506 | D | -2 | -26 | -22 | -12 | -8 | -26 | -2 | 6 | 0 | 5 | 47 | |||
11/21/16 19:14  | 11/18/16  | NVTA | Health | Health | Medical Laboratories | Crouse Geoffrey | CA | D | P | 94 | 6.25 | 3 | 15 | 78 | 34 | D | -10 | -29 | -29 | -25 | -21 | -28 | -29 | 2 | 6 | 11 | 55 | ||||
11/21/16 18:29  | 11/18/16  | NVTA | Health | Health | Medical Laboratories | Aguiar Eric | CA | D | P | 63 | 6.28 | 3 | 10 | New | 10 | D | -10 | -29 | -29 | -25 | -21 | -28 | -29 | 2 | 6 | 11 | 55 | ||||
11/18/16 16:36  | 11/17/16  | NVTA | Health | Health | Medical Laboratories | Baker Bros. Advisors LP | NY | T | P | 4,400 | 6.00 | 3 | 733 | 13 | 6,554 | I | -11 | -26 | -29 | -28 | -18 | -23 | -30 | 13 | 21 | 19 | 69 | ||||
2/12/16 17:00  | 2/11/16  | NVTA | Health | Health | Medical Laboratories | George Sean E | CA | DO | P,COO | P | 104 | 6.16 | 1 | 17 | 8 | 235 | D | -27 | -9 | -21 | -18 | -7 | -7 | 3 | 16 | 34 | 37 | 39 | 39 | ||
8/13/15 16:30  | 8/11/15  | NVTA | Health | Health | Medical Laboratories | George Sean E | CA | DO | P,COO | P.m | 458 | 9.18 | 2 | 50 | 30 | 218 | D | -28 | -40 | -20 | -9 | -11 | -2 | 0 | 25 | -18 | -25 | 1 | |||
2/19/15 19:13  | 2/18/15  | NVTA | Health | Health | Medical Laboratories | Flynn James E | NY | TH | Possible | P.d | 2,800 | 16.00 | 33 | 175 | 105 | 342 | I | 27 | 2 | -6 | -7 | -23 | -53 | -59 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |